Peter Heinrich Krammer

Q: What Schools Are Affiliated With Peter Heinrich Krammer

Peter Heinrich Krammer is affiliated with the following schools: University of Tübingen, University of Texas Southwestern Medical Center

Peter Heinrich Krammer's AcademicInfluence.com Rankings

Biology

#3245

World Rank

#4985

Historical Rank

Cell Biology

#67

World Rank

#71

Historical Rank

Molecular Biology

#218

World Rank

#222

Historical Rank

Neuroscience

#298

World Rank

#314

Historical Rank

biology Degrees

Download Badge

Biology

Peter Heinrich Krammer's Degrees

PhD Molecular Biology University of California, Berkeley
Bachelors Biochemistry Stanford University

Why Is Peter Heinrich Krammer Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Peter Heinrich Krammer's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Two CD95 (APO‐1/Fas) signaling pathways (1998) (3290)
FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex (1996) (3233)
Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor. (1995) (2325)
Death and anti-death: tumour resistance to apoptosis (2002) (1955)
Monoclonal antibody-mediated tumor regression by induction of apoptosis. (1989) (1839)
CD95's deadly mission in the immune system (2000) (1802)
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) (1995) (1789)
FLICE is activated by association with the CD95 death‐inducing signaling complex (DISC) (1997) (1307)
The CD95(APO-1/Fas) DISC and beyond (2003) (1137)
Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells (1996) (1075)
Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120 (1995) (1039)
Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand–expressing tumor cells — A mechanism of immune evasion? (1996) (959)
The Role of c-FLIP in Modulation of CD95-induced Apoptosis* (1999) (903)
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs (1998) (898)
FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. (2000) (830)
FADD/MORT1 Is a Common Mediator of CD95 (Fas/APO-1) and Tumor Necrosis Factor Receptor-induced Apoptosis (*) (1996) (804)
Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. (1997) (794)
Bcl‐2 and Fas/APO‐1 regulate distinct pathways to lymphocyte apoptosis. (1995) (774)
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage (1995) (731)
Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. (1993) (702)
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. (2000) (661)
Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells* (1999) (658)
Caspases: pharmacological manipulation of cell death. (2005) (639)
Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis (1995) (638)
Life and death in peripheral T cells (2007) (626)
Cellular FLICE-inhibitory Protein Splice Variants Inhibit Different Steps of Caspase-8 Activation at the CD95 Death-inducing Signaling Complex* (2001) (612)
FLICE-Inhibitory Proteins: Regulators of Death Receptor-Mediated Apoptosis (2001) (583)
Molecular Mechanisms of Treg-Mediated T Cell Suppression (2012) (574)
Death receptors in chemotherapy and cancer (2004) (528)
Activation interferes with the APO-1 pathway in mature human T cells. (1993) (515)
Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. (1998) (514)
Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. (1990) (476)
Death receptor signaling (2005) (469)
Immune escape of tumors: apoptosis resistance and tumor counterattack (2002) (452)
FLICE Is Predominantly Expressed as Two Functionally Active Isoforms, Caspase-8/a and Caspase-8/b* (1997) (449)
CD95(APO-1/Fas)-mediated apoptosis: live and let die. (1999) (441)
Cell nucleus and DNA fragmentation are not required for apoptosis (1994) (439)
Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis (2005) (434)
T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells (1982) (414)
HIV‐1 Tat potentiates TNF‐induced NF‐kappa B activation and cytotoxicity by altering the cellular redox state. (1995) (402)
Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor. (1984) (396)
Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1 (1985) (395)
Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. (1994) (376)
Activation of Mitochondria and Release of Mitochondrial Apoptogenic Factors by Betulinic Acid* (1998) (365)
Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. (1997) (359)
Regulation of apoptosis in the immune system. (1994) (347)
Expression of APO‐1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium (1994) (337)
Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis (2004) (329)
Divergent signalling via APO‐1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. (1994) (327)
CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway (1995) (317)
Regulation of CD95/Fas signaling at the DISC (2011) (317)
Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. (2000) (315)
Regulation of death receptor-mediated apoptosis pathways. (2000) (303)
Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. (1992) (290)
TAp63α induces apoptosis by activating signaling via death receptors and mitochondria (2005) (281)
c-FLIPR, a New Regulator of Death Receptor-induced Apoptosis* (2005) (280)
Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1 /Fas) Mediated apoptosis (1998) (278)
Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. (1998) (272)
CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. (1997) (264)
The Role of APO‐1‐Mediated Apoptosis in the Immune System (1994) (253)
Prevalence of Newly Generated Naive Regulatory T Cells (Treg) Is Critical for Treg Suppressive Function and Determines Treg Dysfunction in Multiple Sclerosis1 (2007) (242)
Artesunate Induces ROS-Mediated Apoptosis in Doxorubicin-Resistant T Leukemia Cells (2007) (236)
Regulation of cell surface APO‐1/Fas (CD95) ligand expression by metalloproteases (1995) (233)
Apoptosis signaling in lymphocytes. (1999) (226)
Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage (1998) (221)
The apoptosis-1/Fas protein in human systemic lupus erythematosus. (1994) (215)
Upregulation of bcl‐2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines (2002) (214)
Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury (2004) (212)
Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke (2001) (212)
Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs (2004) (211)
CXCR4 and CD4 mediate a rapid CD95-independent cell death in CD4(+) T cells. (1998) (210)
The role of CD95 in the regulation of peripheral T‐cell apoptosis (2003) (209)
Local Fas/APO‐1 (CD95) ligand‐mediated tumor cell killing in vivo (1995) (208)
MAPK/ERK signaling in activated T cells inhibits CD95/Fas‐mediated apoptosis downstream of DISC assembly (2000) (207)
Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas. (2003) (204)
Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells. (2000) (197)
The death receptors. (1999) (196)
Resistance of cultured peripheral T cells towards activation‐induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death‐inducing signaling complex (1997) (196)
Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. (1994) (194)
Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells (1994) (192)
APO‐1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: Correlation with bcl‐2 oncogene expression (1993) (192)
Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. (2006) (190)
Reactive Oxygen Intermediates Are Involved in the Induction of CD95 Ligand mRNA Expression by Cytostatic Drugs in Hepatoma Cells* (1997) (190)
Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. (1999) (187)
Vacuolating Cytotoxin of Helicobacter pylori Induces Apoptosis in the Human Gastric Epithelial Cell Line AGS (2001) (183)
Surface expression of TRAIL/Apo‐2 ligand in activated mouse T and B cells (1998) (183)
Regulation of IL4 gene expression by T cells and therapeutic perspectives (2003) (181)
Stoichiometry of the CD95 death-inducing signaling complex: experimental and modeling evidence for a death effector domain chain model. (2012) (178)
High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. (1994) (178)
The c-FLIP–NH2 terminus (p22-FLIP) induces NF-κB activation (2006) (177)
Mitochondrial Reactive Oxygen Species Control T Cell Activation by Regulating IL-2 and IL-4 Expression: Mechanism of Ciprofloxacin-Mediated Immunosuppression (2010) (177)
Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. (2006) (172)
Structure of the human APO‐1 gene (1994) (169)
TAp73/ΔNp73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma (2005) (169)
Cutting Edge: In Contrast to Effector T Cells, CD4+CD25+FoxP3+ Regulatory T Cells Are Highly Susceptible to CD95 Ligand- but Not to TCR-Mediated Cell Death1 (2005) (167)
Phosphorylation of FADD/ MORT1 at Serine 194 and Association with a 70-kDa Cell Cycle-Regulated Protein Kinase1 (2000) (167)
TAp63 and ΔNp63 in Cancer and Epidermal Development (2007) (167)
The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations. (1999) (165)
Up‐regulation of c‐FLIPshort and reduction of activation‐induced cell death in CD28‐co‐stimulated human T cells (2000) (165)
Molecular Mechanisms of Death‐Receptor‐Mediated Apoptosis (2001) (163)
Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias. (1995) (162)
TCR-Mediated Up-Regulation of c-FLIPshort Correlates with Resistance Toward CD95-Mediated Apoptosis by Blocking Death-Inducing Signaling Complex Activity1 (2000) (162)
Flice-Inhibitory Protein Is a Key Regulator of Germinal Center B Cell Apoptosis (2001) (161)
Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. (1998) (160)
Interleukin 1β-converting Enzyme Related Proteases/Caspases Are Involved in TRAIL-induced Apoptosis of Myeloma and Leukemia Cells (1997) (159)
Monoclonal-antibody-mediated apoptosis in adult T-cell leukaemia (1990) (156)
Model-based dissection of CD95 signaling dynamics reveals both a pro- and antiapoptotic role of c-FLIPL (2010) (155)
Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma. (2006) (152)
Dynamics within the CD95 death-inducing signaling complex decide life and death of cells (2010) (152)
Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children. (1996) (152)
p73 induces apoptosis by different mechanisms. (2005) (150)
Identification of the Cytolinker Plectin as a Major Early In Vivo Substrate for Caspase 8 during CD95- and Tumor Necrosis Factor Receptor-Mediated Apoptosis (2000) (150)
IFN-γ Represses IL-4 Expression via IRF-1 and IRF-2 (2002) (150)
One, two, three--p53, p63, p73 and chemosensitivity. (2006) (147)
In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death. (2005) (146)
APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. (1993) (145)
Concepts of activated T cell death. (2008) (144)
Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. (1996) (144)
CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases. (1996) (144)
Pharmacologic cholinesterase inhibition improves survival in experimental sepsis* (2008) (142)
Regulation of germinal center B cell differentiation. Role of the human APO-1/Fas (CD95) molecule. (1995) (142)
T cell activation is driven by an ADP-dependent glucokinase linking enhanced glycolysis with mitochondrial reactive oxygen species generation. (2012) (141)
B cell-stimulatory factor 1 (BSF-1) promotes growth of helper T cell lines (1986) (141)
Apoptosis in cancer--implications for therapy. (2004) (140)
Knockout of myeloid cell leukemia‐1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes (2009) (138)
Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCgamma1- and Ca2+-dependent apoptosis. (2008) (137)
Activation of the CD95 (APO-1/Fas) pathway in drug- and γ-irradiation-induced apoptosis of brain tumor cells (1998) (136)
Concurrent engagement of CD40 and the antigen receptor protects naive and memory human B cells from APO-1/Fas-mediated apoptosis (1996) (134)
CD95-induced apoptosis in human liver disease. (1998) (134)
Production of immune interferon by murine T-cell clones from long-term cultures (1981) (134)
A Novel AP-1 Element in the CD95 Ligand Promoter Is Required for Induction of Apoptosis in Hepatocellular Carcinoma Cells upon Treatment with Anticancer Drugs (2000) (132)
Upregulation of Major Histocompatibility Complex Class I on Liver Cells by Hepatitis C Virus Core Protein via p53 and TAP1 Impairs Natural Killer Cell Cytotoxicity (2003) (130)
Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants (2003) (130)
TAp63 and DeltaNp63 in cancer and epidermal development. (2007) (130)
Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus. (2007) (130)
Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1 (2011) (129)
The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2. (2012) (128)
DEDD, a novel death effector domain‐containing protein, targeted to the nucleolus (1998) (127)
Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system. (2003) (127)
How T lymphocytes switch between life and death (2006) (126)
Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide. (2000) (125)
Rapid Suppression of Cytokine Transcription in Human CD4+CD25− T Cells by CD4+Foxp3+ Regulatory T Cells: Independence of IL-2 Consumption, TGF-β, and Various Inhibitors of TCR Signaling1 (2007) (125)
Vitamin E inhibits IL‐4 gene expression in peripheral blood T cells (2002) (123)
Novel Role for Mitochondria: Protein Kinase Cθ-Dependent Oxidative Signaling Organelles in Activation-Induced T-Cell Death (2007) (122)
Bcl-xL Acts Downstream of Caspase-8 Activation by the CD95 Death-inducing Signaling Complex* (1998) (121)
Lack of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand But Presence of Its Receptors in the Human Brain (2002) (121)
Control of neuronal branching by the death receptor CD95 (Fas/Apo-1) (2006) (121)
Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax. (1994) (118)
T Cell‐Derived Lymphokines That Induce IgM and IgG Secretion in Activated Murine B Cells (1984) (113)
B-cell growth factor (B-cell growth factor I or B-cell-stimulating factor, provisional 1) is a differentiation factor for resting B cells and may not induce cell growth. (1985) (110)
Most influenza A virus-specific memory cytotoxic T lymphocytes react with antigenic epitopes associated with internal virus determinants (1984) (110)
Coregulation of the APO-1 antigen with intercellular adhesion molecule-1 (CD54) in tonsillar B cells and coordinate expression in follicular center B cells and in follicle center and mediastinal B-cell lymphomas. (1993) (109)
Interleukin 4 mediates autocrine growth of helper T cells after antigenic stimulation. (1986) (107)
Hepatocyte‐specific deletion of the antiapoptotic protein myeloid cell leukemia‐1 triggers proliferation and hepatocarcinogenesis in mice (2010) (107)
Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma. (2009) (107)
CD4+CD25+ regulatory T cells in human lupus erythematosus (2008) (107)
Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. (1992) (106)
Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma. (2006) (106)
Tumor counterattack: fact or fiction? (2005) (105)
Chemotherapy‐induced apoptosis in hepatocellular carcinoma involves the p53 family and is mediated via the extrinsic and the intrinsic pathway (2010) (103)
Resistance of Short Term Activated T Cells to CD95-Mediated Apoptosis Correlates with De Novo Protein Synthesis of c-FLIPshort1 (2004) (102)
Regulation of T cell apoptosis during the immune response. (2002) (101)
CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release (2001) (101)
High-resolution analysis of the human T-cell receptor repertoire (2015) (100)
Primary human hepatocytes--a valuable tool for investigation of apoptosis and hepatitis B virus infection. (2003) (98)
HIV-1 Trans-Activator of Transcription Substitutes for Oxidative Signaling in Activation-Induced T Cell Death 1 (2005) (97)
Proteasome Inhibitor‐Induced Apoptosis of Glioma Cells Involves the Processing of Multiple Caspases and Cytochrome c Release (2000) (96)
Cell surface sialylation plays a role in modulating sensitivity towards APO-1-mediated apoptotic cell death. (1995) (95)
Intracerebral Human Regulatory T Cells: Analysis of CD4+CD25+FOXP3+ T Cells in Brain Lesions and Cerebrospinal Fluid of Multiple Sclerosis Patients (2011) (95)
Regulation of the Fas Death Pathway by FLICE-Inhibitory Protein in Primary Human B Cells1 (2000) (94)
Selective up-regulation of phosphatidylinositol 3'-kinase activity in Th2 cells inhibits caspase-8 cleavage at the death-inducing complex: a mechanism for Th2 resistance from Fas-mediated apoptosis. (1999) (93)
Specific binding of alloantigens to T cells activated in the mixed lymphocyte reaction (1976) (93)
Glucocorticoids inhibit activation-induced cell death (AICD) via direct DNA-dependent repression of the CD95 ligand gene by a glucocorticoid receptor dimer. (2005) (91)
T cell activation‐induced and HIV Tat‐enhanced CD95(APO‐1 / Fas) ligand transcription involves NF‐κB (2000) (90)
Wogonin sensitizes resistant malignant cells to TNFalpha- and TRAIL-induced apoptosis. (2006) (90)
Nuclear factor-IL6 activates the human IL-4 promoter in T cells. (1995) (90)
Involvement of Jun and Rel Proteins in Up-regulation of Interleukin-4 Gene Activity by the T Cell Accessory Molecule CD28* (1998) (90)
The chemotherapeutic drug 5-fluorouracil induces apoptosis in mouse thymocytes in vivo via activation of the CD95(APO-1/Fas) system. (2001) (90)
Caspase activation is required for nitric oxide-mediated, CD95(APO-1/Fas)-dependent and independent apoptosis in human neoplastic lymphoid cells. (1998) (90)
IFN-gamma represses IL-4 expression via IRF-1 and IRF-2. (2002) (89)
Calcium/Calmodulin-dependent Protein Kinase II Regulation of c-FLIP Expression and Phosphorylation in Modulation of Fas-mediated Signaling in Malignant Glioma Cells* (2003) (89)
Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction (2006) (89)
Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes. (1985) (88)
Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas (2006) (88)
Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis. (1995) (87)
The active caspase-8 heterotetramer is formed at the CD95 DISC (2003) (87)
Herpes Simplex Virus Type 1 Infection of Activated Cytotoxic T Cells: Induction of Fratricide as a Mechanism of Viral Immune Evasion (1999) (86)
The life and death of a B cell. (2002) (86)
Novel Egr/NF‐AT composite sites mediate activation of the CD95 (APO‐1/Fas) ligand promoter in response to T cell stimulation (1999) (85)
Clonal analysis of B cells induced to secrete IgG by T cell-derived lymphokine(s) (1984) (85)
Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors (2007) (84)
The regulation of CD95 ligand expression and function in CTL. (1998) (84)
High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade. (2011) (83)
Differences between CD95 type I and type II cells detected with the CD95 ligand [1] (1999) (83)
CD95 (APO-1/Fas)-associating signalling proteins. (1996) (82)
Viral IFN-Regulatory Factors Inhibit Activation-Induced Cell Death Via Two Positive Regulatory IFN-Regulatory Factor 1-Dependent Domains in the CD95 Ligand Promoter1 (2002) (81)
HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP). (2006) (81)
Death receptor signaling and its function in the immune system. (2006) (78)
The traditional Chinese herbal compound rocaglamide preferentially induces apoptosis in leukemia cells by modulation of mitogen‐activated protein kinase activities (2007) (78)
Differential expression of APO‐1 on human thymocytes: Implications for negative selection? (1994) (77)
Analysis of CD95 Threshold Signaling (2007) (76)
The CD95 system and the death of a lymphocyte. (1997) (76)
Lymphokine-induced IgM secretion by clones of neoplastic B cells (1983) (76)
Apoptosis: a general comment (1991) (75)
Immune (dys)regulation in multiple sclerosis: role of the CD95-CD95 ligand system. (1999) (75)
An IL-2-Dependent Switch Between CD95 Signaling Pathways Sensitizes Primary Human T Cells Toward CD95-Mediated Activation-Induced Cell Death 1 (2003) (75)
Phosphatidylinositol 3′-Kinase Blocks CD95 Aggregation and Caspase-8 Cleavage at the Death-Inducing Signaling Complex by Modulating Lateral Diffusion of CD951 (2001) (75)
Resistance to APO-1 (CD95) induced apoptosis in T-ALL is determined by a BCL-2 independent anti-apoptotic program. (1995) (75)
Cytocidal effects of Escherichia coli hemolysin on human T lymphocytes (1993) (74)
TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. (2005) (74)
T cell receptor idiotypes are controlled by genes in the heavy chain linkage group and the major histocompatibility complex (1977) (73)
Rocaglamide Derivatives Are Immunosuppressive Phytochemicals That Target NF-AT Activity in T Cells (2005) (73)
A regulatory element in the CD95 (APO‐1/Fas) ligand promoter is essential for responsiveness to TCR‐mediated activation (1998) (72)
Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death. (2002) (72)
Glutathione Dependence of Caspase-8 Activation at the Death-inducing Signaling Complex* (2002) (72)
APO-1 (CD95)-dependent and -independent antigen receptor-induced apoptosis in human T and B cell lines. (1995) (71)
Fc-receptors, Ia-antigens, and immunoglobulin on normal and activated mouse T lymphocytes (1975) (71)
Early detachment of colon carcinoma cells during CD95(APO-1/Fas)- mediated apoptosis. I. De-adhesion from hyaluronate by shedding of CD44 (1996) (70)
The APO‐1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice (1994) (70)
FOXP3+CD25- tumor cells with regulatory function in Sézary syndrome. (2009) (70)
Th2-specific protein/DNA interactions at the proximal nuclear factor-AT site contribute to the functional activity of the human IL-4 promoter. (1998) (70)
CD127(low/-) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood. (2010) (69)
Constitutive secretion of bioactive transforming growth factor beta 1 by small cell lung cancer cell lines. (1994) (68)
Manganese superoxide dismutase: a regulator of T cell activation-induced oxidative signaling and cell death. (2012) (68)
Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand. (1997) (68)
Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma (2010) (68)
Caspase-2 is activated at the CD95 death-inducing signaling complex in the course of CD95-induced apoptosis. (2006) (68)
Rocaglamide breaks TRAIL resistance in HTLV-1-associated adult T-cell leukemia/lymphoma by translational suppression of c-FLIP expression (2011) (67)
Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells (2000) (67)
Paneth cells express high levels of CD95 ligand transcripts: a unique property among gastrointestinal epithelia. (1996) (66)
Human Regulatory T Cells Rapidly Suppress T Cell Receptor–Induced Ca2+, NF-κB, and NFAT Signaling in Conventional T Cells (2011) (65)
CD95(APO-1/Fas)-mediated apoptosis in normal and malignant liver, colon, and hematopoietic cells. (1998) (65)
Molecular architecture of the DED chains at the DISC: regulation of procaspase-8 activation by short DED proteins c-FLIP and procaspase-8 prodomain (2015) (64)
Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis (2002) (63)
ICE-proteases mediate HTLV-I Tax-induced apoptotic T-cell death (1997) (63)
FasL (CD95L/APO-1L) Resistance of Neurons Mediated by Phosphatidylinositol 3-Kinase-Akt/Protein Kinase B-Dependent Expression of Lifeguard/Neuronal Membrane Protein 35 (2005) (63)
The role of NF-Y and IRF-2 in the regulation of human IL-4 gene expression. (1994) (62)
Annexin A1 on the Surface of Early Apoptotic Cells Suppresses CD8+ T Cell Immunity (2013) (61)
T cell-specific negative regulation of transcription of the human cytokine IL-4. (1992) (61)
Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short). (2001) (61)
Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells. (2005) (60)
Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB. (2016) (60)
Phosphorylation of CARMA1 by HPK1 is critical for NF-κB activation in T cells (2009) (60)
Characterization of regulatory T cells in patients with dermatomyositis. (2010) (59)
Isolation and analysis of components of CD95 (APO-1/Fas) death-inducing signaling complex. (1999) (59)
Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosis (1996) (59)
Activation or suppression of NFκB by HPK1 determines sensitivity to activation‐induced cell death (2005) (59)
Differential interaction of nuclear factors with the PRE-I enhancer element of the human IL-4 promoter in different T cell subsets. (1997) (58)
Modulation of the CD95-Induced Apoptosis: The Role of CD95 N-Glycosylation (2011) (57)
Vav Synergizes with Protein Kinase CΘ to Mediate IL-4 Gene Expression in Response to CD28 Costimulation in T Cells1 (2000) (57)
The role of p53 and the CD95 (APO-1/Fas) death system in chemotherapy-induced apoptosis. (1999) (57)
Death ligand/receptor-independent caspase activation mediates drug-induced cytotoxic cell death in human malignant glioma cells (1999) (55)
A PP4 holoenzyme balances physiological and oncogenic nuclear factor-kappa B signaling in T lymphocytes. (2012) (55)
T cell-derived B cell growth and differentiation factors. Dichotomy between the responsiveness of B cells from adult and neonatal mice (1983) (54)
Lack of T-cell receptor-induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death. (2009) (54)
Foxp3-Mediated Suppression of CD95L Expression Confers Resistance to Activation-Induced Cell Death in Regulatory T Cells (2011) (54)
Macrophage-activating factors from different T cell clones induce distinct macrophage functions. (1983) (53)
CD95 Stimulation Results in the Formation of a Novel Death Effector Domain Protein-containing Complex* (2008) (53)
Understanding apoptosis by systems biology approaches. (2009) (53)
Mitochondria as Oxidative Signaling Organelles in T-cell Activation: Physiological Role and Pathological Implications (2013) (52)
Manganese‐enhanced magnetic resonance imaging for in vivo assessment of damage and functional improvement following spinal cord injury in mice (2006) (52)
Segregation of APO‐1/Fas antigen‐ and tumor necrosis factor receptor‐mediated apoptosis (1994) (52)
The human APO-1 (APT) antigen maps to 10q23, a region that is syntenic with mouse chromosome 19. (1992) (51)
Herpes Simplex Virus Type 1 Infection of Activated Cytotoxic T Cells (1999) (51)
Critical role for mitochondria in B cell receptor-mediated apoptosis. (2000) (50)
A New C-Terminal Cleavage Product of Procaspase-8, p30, Defines an Alternative Pathway of Procaspase-8 Activation (2009) (50)
Differences between CD95 type I and II cells detected with the CD95 ligand. (1999) (48)
The CD95(APO-1/Fas)/CD95L system. (1998) (47)
Targeting CDK9 by wogonin and related natural flavones potentiates the anti‐cancer efficacy of the Bcl‐2 family inhibitor ABT‐263 (2014) (46)
Dominant negative (DeltaN) p63alpha induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways. (2010) (45)
Selective suppression of cytokine secretion in patients with small-cell lung cancer. (1995) (45)
2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation (2012) (45)
Modulation of CD4+ T-cell activation by CD95 co-stimulation (2011) (45)
Alloantigen receptors on activated T cells in mice. I. Binding of alloantigens and anti-idiotypic antibodies to the same receptors (1978) (44)
A novel enhancer element in the human IL-4 promoter is suppressed by a position-independent silencer. (1993) (44)
Murine thymic lymphomas as model tumors for T-cell studies. T-cell markers, immunoglobulin and Fc-receptors on AKR thymomas. (1976) (43)
Caspase-8 activity has an essential role in CD95/Fas-mediated MAPK activation (2011) (43)
Induction of apoptosis by IFNγ in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit (1999) (43)
No life without death. (2007) (43)
Curcumin Suppresses T Cell Activation by Blocking Ca2+ Mobilization and Nuclear Factor of Activated T Cells (NFAT) Activation (2012) (42)
CD95 Ligand-Expressing Tumors Are Rejected in Anti-Tumor TCR Transgenic Perforin Knockout Mice (2001) (42)
Resistance to CD95 (APO-1/Fas)-mediated apoptosis in human renal cell carcinomas: an important factor for evasion from negative growth control. (1999) (42)
Dectin-1 Binding to Annexins on Apoptotic Cells Induces Peripheral Immune Tolerance via NADPH Oxidase-2. (2019) (41)
CD95 ligand (CD95L) in normal human lymphoid tissues: a subset of plasma cells are prominent producers of CD95L. (1999) (41)
S-adenosylhomocysteine as a physiological modulator of Apo-1-mediated apoptosis. (1996) (41)
An unexpected role for FosB in activation-induced cell death of T cells (2003) (41)
Constitutive interleukin 2 production by the JURKAT human leukemic T cell line (1982) (40)
Deficient activation of CD95 (APO-1/ Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma (2000) (40)
Activated T killer cells induce apoptosis in lung epithelial cells and the release of pro‐inflammatory cytokine TNF‐α (2004) (40)
Src Homology 2 Domain-Containing Leukocyte Phosphoprotein of 76 kDa and Phospholipase Cγ1 Are Required for NF-κB Activation and Lipid Raft Recruitment of Protein Kinase Cθ Induced by T Cell Costimulation1 (2003) (39)
Ethanol-induced apoptosis in hepatoma cells proceeds via intracellular Ca(2+) elevation, activation of TLCK-sensitive proteases, and cytochrome c release. (2001) (39)
Activation or suppression of NFkappaB by HPK1 determines sensitivity to activation-induced cell death. (2005) (39)
A monoclonal anti-mouse LFA-1 alpha antibody mimics the biological effects of B cell stimulatory factor-1 (BSF-1). (1986) (39)
Rescue of death receptor and mitochondrial apoptosis signaling in resistant human NSCLC in vivo (2004) (38)
Frequencies and regulation of trinitrophenyl-specific cytotoxic T precursor cells: immunization results in release from suppression. (1983) (38)
Active transcription of the human FAS/CD95/TNFRSF6 gene involves the p53 family. (2009) (37)
Anti‐annexin 1 antibodies: A new diagnostic marker in the serum of patients with discoid lupus erythematosus (2010) (37)
The traditional Chinese medical compound Rocaglamide protects nonmalignant primary cells from DNA damage-induced toxicity by inhibition of p53 expression (2014) (37)
Ultraviolet Irradiation Suppresses T Cell Activation via Blocking TCR-Mediated ERK and NF-κB Signaling Pathways (2005) (37)
Priming and triggering of tumoricidal and schistosomulicidal macrophages by two sequential lymphokine signals: interferon-gamma and macrophage cytotoxicity inducing factor 2. (1985) (36)
Sustained JNK signaling by proteolytically processed HPK1 mediates IL-3 independent survival during monocytic differentiation (2007) (36)
Caspase-cleaved HPK1 induces CD95L-independent activation-induced cell death in T and B lymphocytes. (2007) (36)
Early Growth Response Protein-1 (Egr-1) Is Preferentially Expressed in T Helper Type 2 (Th2) Cells and Is Involved in Acute Transcription of the Th2 Cytokine Interleukin-4* (2009) (36)
Cutaneous CD30+ lymphoproliferative disorders: expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamily. (1998) (36)
Cervical cancer cells induce apoptosis of cytotoxic T lymphocytes. (2000) (36)
The death of a T-cell: expression of the CD95 ligand (2002) (35)
The anti-inflammatory sesquiterpene lactone parthenolide suppresses CD95-mediated activation-induced-cell-death in T-cells (2002) (35)
Construction of optimized bispecific antibodies for selective activation of the death receptor CD95. (2008) (34)
Targeting the IL‐4/IL‐13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs (2013) (34)
Production of colony-stimulating factors by murine T cells in limiting dilution and long-term cultures (1982) (34)
Decrease of interleukin-2 secretion is a new independent prognostic factor associated with poor survival in patients with small-cell lung cancer. (1997) (33)
Enhanced expression of thioredoxin‐interacting‐protein regulates oxidative DNA damage and aging (2018) (33)
Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma. (2010) (33)
The effect of HIV‐1 regulatory proteins on cellular genes: derepression of the IL‐2 promoter by Tat (2001) (32)
Erratum: The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations (Journal of Clinical Investigation (1999) 103 (355- 363)) (1999) (32)
APO-1 (CD95) mediated apoptosis in human T-ALL engrafted in SCID mice. (1994) (31)
Cloning of the cDNA encoding human C/EBP gamma, a protein binding to the PRE-I enhancer element of the human interleukin-4 promoter. (1995) (31)
CD95L mediates tumor counterattack in vitro but induces neutrophil‐independent tumor rejection in vivo (2005) (31)
The role of CAP3 in CD95 signaling: new insights into the mechanism of procaspase-8 activation (2006) (31)
Fractionated γ-irradiation renders tumour cells more responsive to apoptotic signals through CD95 (1999) (31)
The tumor strikes back: New data on expression of the CD95(APO-1/Fas) receptor/ligand system may cause paradigm changes in our view on drug treatment and tumor immunology (1997) (31)
Target cell-restricted triggering of the CD95 (APO-1/Fas) death receptor with bispecific antibody fragments. (2001) (31)
Internalization of interleukin 1 (IL 1) correlates with IL 1‐induced IL 2 receptor expression and IL 2 secretion of EL4 thymoma cells (1989) (31)
Dual role of the anti-inflammatory sesquiterpene lactone: regulation of life and death by parthenolide (2005) (30)
Small and large B cells respond differently to T cell-derived B cell growth and differentiation factors. (1985) (30)
T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappaB. (2000) (30)
Transforming Growth Factor-β–Mediated Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Expression and Apoptosis in Hepatoma Cells Requires Functional Cooperation between Smad Proteins and Activator Protein-1 (2008) (30)
Apoptotic signal molecules in skin biopsies of cutaneous lupus erythematosus: analysis using tissue microarray (2013) (30)
Rocaglamide sensitizes leukemic T cells to activation-induced cell death by differential regulation of CD95L and c-FLIP expression (2009) (30)
LEF-1 Negatively Controls Interleukin-4 Expression through a Proximal Promoter Regulatory Element* (2008) (29)
A new assay for interleukin-1 in the presence of interleukin-2. (1987) (29)
Alternative splicing of caspase-8 mRNA during differentiation of human leukocytes. (2001) (28)
A method for testing the specificity of influenza A virus-reactive memory cytotoxic T lymphocyte (CTL) clones in limiting dilution cultures. (1984) (27)
The natural anticancer compound rocaglamide selectively inhibits the G1‐S‐phase transition in cancer cells through the ATM/ATR‐mediated Chk1/2 cell cycle checkpoints (2014) (27)
Transforming growth factor β can mediate apoptosis via the expression of TRAIL in human hepatoma cells (2005) (27)
Pathophysiology of cutaneous lupus erythematosus--novel aspects. (2006) (26)
The Protein Phosphatase 2A Regulatory Subunit B56γ Mediates Suppression of T Cell Receptor (TCR)-induced Nuclear Factor-κB (NF-κB) Activity* (2014) (26)
Apoptotic cell death induced by a mouse‐human anti‐APO‐1 chimeric antibody leads to tumor regression (1994) (26)
Similar sensitivity of regulatory T cells towards CD95L-mediated apoptosis in patients with multiple sclerosis and healthy individuals (2006) (26)
Tax contributes apoptosis resistance to HTLV-1-infected T cells via suppression of Bid and Bim expression (2014) (26)
The CD95(APO-1/Fas) receptor/ligand system: death signals and diseases. (1996) (25)
CD95 expression and CD95-mediated apoptosis of T cells in multiple sclerosis No differences from normal individuals and no relation to HLA-DR2 (1998) (25)
When apoptosis fails (1992) (25)
Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors (2006) (25)
Mangrove dolabrane‐type of diterpenes tagalsins suppresses tumor growth via ROS‐mediated apoptosis and ATM/ATR–Chk1/Chk2‐regulated cell cycle arrest (2015) (25)
Effect of T cell-derived lymphokines containing B cell differentiation factor(s) for IgG (BCDFγ) on γ-specific mRNA in murine B cells (1983) (25)
ΔNp73β is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondria (2010) (25)
IL-1 induces high affinity IL-2 receptor expression of CD4-8- thymocytes. (1989) (24)
The T-cell receptor problem. (1981) (24)
21 – Production of Lymphokines by Murine T Cells Grown in Limiting Dilution and Long-Term Cultures (1982) (24)
AIDS and the death receptors. (1997) (24)
Expression of biologically active mouse and human CD95/APO-1/Fas ligand in the baculovirus system. (1996) (24)
Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus Type 1 (HIV-1)-infected children (1998) (23)
What controls tissue-specific expression of the IL-4 gene? (1997) (23)
Characterization of constitutive and inducible transcription factors binding to the P2 NF-AT site in the human interleukin-4 promoter. (1997) (23)
The anticancer phytochemical rocaglamide inhibits Rho GTPase activity and cancer cell migration (2016) (23)
The Tolerogenic Function of Annexins on Apoptotic Cells Is Mediated by the Annexin Core Domain (2015) (23)
NF-kappa B synergizes with NF-AT and NF-IL6 in activation of the IL-4 gene in T cells. (2004) (22)
Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin (2018) (22)
Tumor dormancy and cell signaling: anti-mu-induced apoptosis in human B-lymphoma cells is not caused by an APO-1-APO-1 ligand interaction. (1996) (21)
Clonal deletion of major histocompatibility complex class I‐restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO‐1/Fas) ligand (1995) (21)
In the mixed lymphocyte reaction. (1976) (21)
Analysis of FOXP3+ regulatory T cell subpopulations in peripheral blood and tissue of patients with systemic lupus erythematosus (2017) (21)
An NF‐χB‐like element plays an essential role in interleukin‐1‐mediated costimulation of the mouse interleukin‐2 promoter (1993) (20)
Rocaglamide breaks TRAIL-resistance in human multiple myeloma and acute T-cell leukemia in vivo in a mouse xenogtraft model. (2017) (20)
Simultaneous in situ detection of mRNA and apoptotic cells by combined hybridization and TUNEL. (1996) (20)
Analysis of the CD95 (APO-1/Fas) death-inducing signaling complex by high-resolution two-dimensional gel electrophoresis. (2000) (20)
Long-term survival in small cell lung cancer patients is correlated with high interleukin-2 secretion at diagnosis (2000) (20)
CREB function is required for normal thymic cellularity and post‐irradiation recovery (2004) (20)
The chains of death (2013) (20)
Antigen receptors on major histocompatibility complex-restricted T lymphocytes. I. Preparation and characterization of syngeneic antisera against trinitrophenyl-activated T cell blasts and demonstration of their specificity for idiotypes on cytotoxic T lymphocytes (1980) (20)
In vitro generated human memory‐like T cells are CD95 type II cells and resistant towards CD95‐mediated apoptosis (2006) (19)
Molecular mechanisms of APO-1/Fas(CD95)-mediated apoptosis in tolerance and AIDS. (1995) (19)
Tumor Necrosis Factor-related Apoptosis-inducing Ligand Retains Its Apoptosis-inducing Capacity on Bcl-2-or Bcl-xL-overexpressing Chemotherapy-resistant Tumor Cells 1 (2000) (19)
Human T cell leukemia virus type I Tax enhances IL‐4 gene expression in T cells (2001) (18)
Combinatorial treatment of CD95L and gemcitabine in pancreatic cancer cells induces apoptotic and RIP1-mediated necroptotic cell death network. (2015) (18)
Up‐regulation of Fas (CD95) expression in tumour cells in vivo (2007) (18)
Ultrastructural analysis of apoptosis induced by the monoclonal antibody anti-APO-1 on a lymphoblastoid B cell line. (1990) (18)
Production of high titres of interferon-gamma by cells derived from short-term cultures of murine spleen leukocytes in T-cell growth factor-conditioned medium. (1982) (18)
Activation of macrophages by lymphokines from T-cell clones: evidence for different macrophage-activating factors. (1984) (17)
19 – Clonal Analysis of Helper and Cytolytic T Cells: Multiple, Independently Regulated Precursor Sets at Frequencies Suggesting a Limited Repertoire (1982) (17)
Activation of the γ1 gene by lipopolysaccharide and T cell-derived lymphokines containing a B cell differentiation factor for IgG1 (BCDFγ) (1985) (17)
Targeting Thioredoxin-1 by dimethyl fumarate induces ripoptosome-mediated cell death (2017) (17)
Assignment of CASP81 to human chromosome band 2q33→q34 and Casp82 to the murine syntenic region on chromosome 1B-proximal C by in situ hybridization (1998) (17)
Derangement of apoptosis in cancer (2001) (17)
The effects of cytokines and adherent cells on the interleukin 4-mediated induction of Ia antigens on resting B cells. (1987) (16)
Interleukin-2 does not induce murine B cells to secrete Ig. (1982) (16)
A −436C>A Polymorphism in the Human FAS Gene Promoter Associated with Severe Childhood Malaria (2011) (16)
The influence of CD95L expression on tumor rejection in mice (2003) (16)
Apoptosis in the Apo-1 system (1991) (16)
Selection of bacterial mutants from Salmonella specifically recognizing determinants on the cell surface of activated T lymphocytes A novel system to define cell surface structures (1980) (15)
Src homology 2 domain-containing leukocyte phosphoprotein of 76 kDa and phospholipase C gamma 1 are required for NF-kappa B activation and lipid raft recruitment of protein kinase C theta induced by T cell costimulation. (2003) (15)
The two CD95 apoptosis signaling pathways may be a way of cells to respond to different amounts and/or forms of CD95 ligand produced in different tissues (2000) (14)
Abstracts of the 35th American Cytogenetics Conference (1998) (14)
Transforming growth factor beta can mediate apoptosis via the expression of TRAIL in human hepatoma cells. (2005) (14)
Interferon-α Abrogates the Suppressive Effect of Apoptotic Cells on Dendritic Cells in an In Vitro Model of Systemic Lupus Erythematosus Pathogenesis (2013) (14)
Wogonin sensitizes resistant malignant cells to TNFα-and TRAIL-induced apoptosis. Commentary (2006) (13)
Lack of interleukin-2 (IL-2) dependent growth of TAC positive T-ALL/NHL cells is due to the expression of only low affinity receptors for IL-2. (1989) (13)
Activation of murine B cells from different tissues with different mitogens. II. Isotype distribution of secreted immunoglobulins in the presence and absence of IL-4-containing T cell supernatants. (1987) (13)
The Wilms' tumor suppressor WT1 enhances CD95L expression and promotes activation‐induced cell death in leukemic T cells (2014) (13)
Neutralization of CD95 ligand protects the liver against ischemia-reperfusion injury and prevents acute liver failure (2018) (13)
The Effect of Anti‐Immunoglobulin Antibodies on Fc Rosettes (1976) (12)
Supplemental Information Stoichiometry of the CD 95 Death-Inducing Signaling Complex : Experimental and Modeling Evidence for a Death Effector Domain Chain Model (2012) (12)
TNF-a stimulation enhances ROS-dependent cell migration via NF-?B activation in liver cells. (2014) (11)
Activation of T cells by interleukin 1 involves internalization of interleukin 1. (1989) (11)
T cell-derived b cell differentiation factor(s) effect on the isotype switch of murine b cells (2013) (11)
The 5' region of the human interleukin 4 gene: structure and potential regulatory elements. (1988) (11)
Killing of schistosomula of Schistosoma mansoni by macrophages: induction by T-cell clone-derived lymphokines and interferon-gamma (1986) (10)
Activation of the mouse IL-2 gene by okadaic acid: synergy with interleukin-1. (1994) (10)
Activation-induced T cell death (1996) (9)
Induction of IL 2 receptor expression and cytotoxicity of thymocytes by stimulation with TCF1. (1985) (9)
In vivo activation of macrophages by T cell-derived lymphokines: killing of tumor cells and schistosomula of Schistosoma mansoni. (1986) (9)
Life, death and tolerance. (2017) (8)
The internalized interleukin-1 activation complex in fibroblasts localizes to the Golgi apparatus. (1995) (8)
Modulating Lateral Diffusion of CD95 Death-Inducing Signaling Complex by Aggregation and Caspase-8 Cleavage at the -Kinase Blocks CD95 ¢ Phosphatidylinositol 3 (2001) (8)
Does the Caenorhabditis elegans protein CED-4 contain a region of homology to the mammalian death effector domain? (1997) (8)
Maturation of fetal thymocytes in organ culture: secretion of interleukin 2, interferon and colony stimulating factors. (1985) (7)
Preactivation of macrophages in mice acutely infected with Schistosoma mansoni. (1988) (7)
T CELL-DERIVED B CELL DIFFERENTIATION FACTORS: (BCDF) : DEFINITION OF BCDFμ AND BCDFγ (1982) (7)
CXCR 4 and CD 4 mediate a rapid CD 95-independent cell death in CD 4 1 T cells (1998) (7)
Specificity of anti-human CD95 (APO-1/Fas) antibodies. (2002) (7)
Two-Step Coimmunoprecipitation (TIP) Enables Efficient and Highly Selective Isolation of Native Protein Complexes * (2017) (7)
Combined inhibition of Bcl-2 and NFκB synergistically induces cell death in cutaneous T-cell lymphoma (2019) (7)
Two FLICE isoforms (Caspase 8/a and Caspase 8/b) are both recruited and activated by the CD95 death inducing signaling complex (DISC) (1997) (7)
Dimethyl fumarate (DMF) therapy in CTCL: results from a clinical phase II study. (2021) (6)
Autocrine growth factors secreted by the malignant human B-cell-line BJAB are distinct from other known cytokines. (1990) (6)
Lack of proapoptotic activity of soluble CD95 ligand is due to its failure to induce CD95 oligomers. (2003) (6)
Survival from Cecal Ligation and Puncture and the Formation of Fibrous Adhesions in the Peritoneal Cavity Depend on Endogenous Tumor Necrosis Factor (1993) (6)
CD95 (APO-1/Fas) and its ligand in the mouse immune system. (1996) (6)
NRAS mutations in cutaneous T cell lymphoma (CTCL) sensitize tumors towards treatment with the multikinase inhibitor Sorafenib (2017) (6)
Different Cytokines with Autocrine and Immunosuppressive Activities are Secreted by a Small-Cell Lung Cancer Cell Line (1992) (5)
Genetics of the idiotype of strain AKR antibodies to group A streptococcal carbohydrate; further evidence for a low degree of homology in the VH chromosomal region. (1978) (5)
Combined inhibition of Bcl-2 and NFκB synergistically induces cell death and limits xenograft mouse tumor growth in CTCL. (2019) (5)
An ovalbumin peptide-specific cytotoxic T cell clone with antigen self-presentation capacity uses two distinct mechanisms to kill target cells. (1993) (5)
immunodeficiency virus type-1-infected children Activation of the CD95 (APO-1/Fas) system in T cells from human (2011) (5)
The effect of T cell-derived lymphokines on the levels of isotype-specific RNA in normal B cells. (1985) (5)
Life and Death Decisions in the CD95 System: Main Pro-and Anti-Apoptotic Modulators (2009) (5)
HIV-1 Tat protein: Chemical synthesis and structural characterisation (1995) (5)
A Recombinant Bispecific CD20×CD95 Antibody With Superior Activity Against Normal and Malignant B-cells. (2016) (5)
T cell-derived B cell growth (BCGF) and differentiation (BCDF) factors: suppression of the activity of BCDF mu but not BCGF by murine bone marrow cells. (1983) (5)
Enhancement of cisplatin-induced apoptosis by infection with adeno-associated virus type 2 (2001) (5)
Advances in Brief Regulation of Tumor Necrosis Factor-related Apoptosis-inducing Ligand Sensitivity in Primary and Transformed Human Keratinocytes 1 (2000) (5)
The role of CD95/CD95 Ligand Signaling in Apoptosis and Cancer (2008) (4)
Characterize Different Regulatory T-Cell Populations in Human Peripheral Blood (2010) (4)
Mitogen-induced χ-interferon (χ-IFN) production by murine T cell clones from long term cultures (1981) (4)
Understanding life and death at CD95. (2011) (4)
Genetic control of idiotypes of T cell receptors for antigen (1978) (4)
Upregulation of the CD95 (apo-1/fas) receptor/ ligand system in peripheral blood T cells from hiv-1-infected children and adults (1996) (4)
The effect of phorbol-myristate acetate and concanavalin A on the growth of interleukin-2-dependent T-cell lines. (1982) (4)
Activation of the CD 95 ( APOl / Fas ) System in T Cells From Human Immunodeficiency Virus Type-l-Infected Children (2002) (4)
T cell hybrids (1983) (3)
Annexin-coated particles induce antigen-specific immunosuppression (2020) (3)
[Expression of APO-1, a cell surface molecule mediating apoptosis, during normal B cell ontogeny and in B cell tumors. Co-expression and coregulation of APO-1 and ICAM-1 (CD54) in germinal central cells]. (1992) (3)
H. Pylori-induced gastric epithelial apoptosis is mediated by the CD95 (Fas) receptor and ligand system (1998) (3)
GROWTH OF DOUBLE-NEGATIVE (L3T4 AND LYT2) MOUSE THYMOCYTES IS INITIATED BY THE COMBINED ACTION OF INTERLEUKIN-1 (IL-1) AND INTERLEUKIN-2 (IL-2) (1987) (3)
Naïve regulatory T cells: a novel subpopulation defined by resistance towards CD95L-mediated cell death Running Head: Naïve Treg and apoptosis resistance (2006) (3)
Induction of apoptosis by IFNγ in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit (2015) (3)
A simple micromethod for MLC and CML with low numbers of murine lymph node and peripheral blood lymphocytes. (1981) (3)
Suppression of apoptosis in COLO 205 cells by the phorbol ester TPA may be mediated by the PKC isoenzyme alpha. (1997) (3)
The role of T cell clone- and hybridoma-derived lymphokines in macrophage activation (1985) (3)
APO-I-mediated apoptosis in normal and malignant lymphocytes. (1994) (2)
Effect of T cell-derived lymphokines containing B cell differentiation factor(s) for IgG (BCDF gamma) on gamma-specific mRNA in murine B cells. (1983) (2)
PRIMING AND TRIGGERING OF TUMORICIDAL AND SCHISTOSOMULICIDAL AND MACROPHAGE CYTOTOXICITY INDUCING FACTOR 2l (1985) (2)
Production of lymphokines derived from fusions of the AKR T-cell tumor BW5147 and selected high-producer T-cell clones in long-term culture☆☆☆ (1982) (2)
FLICE is involved in regulation of activation-induced cell death (AICD) of peripheral T cells (1997) (2)
Lymphocyte Activation Induced Apoptosis by the APO-1 Cell Surface Receptor (1994) (2)
Biological effects of a rat monoclonal anti-mouse IFN-gamma antibody produced by in vitro immunization. (1987) (2)
1 Caspase Cleaved HPK 1 Induces CD 95 L-Independent Activation-Induced Cell Death in T and B Lymphocytes (2007) (2)
The c-FLIP–NH 2 terminus (p22-FLIP) induces NF- κ B activation (2006) (2)
1 c-FLIP splice variants inhibit different steps of caspase-8 activation at the CD 95 death-inducing signaling complex ( DISC ) * (2001) (2)
Does TGF β1 Play a Role in Immunosuppression in Small-Cell Lung Cancer? (1995) (2)
Detection of active infection of Sf9 insect cells by recombinant baculoviruses. (1997) (2)
EMBO workshop on cytotoxicity, cell death and the immune system (2009) (1)
The activity of lymphokines secreted by normal and malignant T cells (1984) (1)
CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: A pathologenetic role for the CD9S/CD95 ligand-system in ulcerative colitis (1996) (1)
Inhibition of Constitutively Activated NF-κB Induces ROSdependent Cell Death in T Cell Lymphoma (2010) (1)
MHC restriction and T cell receptors. (1981) (1)
CD4/CXCR4-mediated cell death in AIDS (2007) (1)
Cycle-Regulated Protein Kinase 194 and Association with a 70-kDa Cell Phosphorylation of FADD / MORT 1 at Serine (2000) (1)
NF-Y, IRF-2, and C/EBP proteins are involved in regulation of human IL-4 gene expression. (1995) (1)
Growth Control of Normal and Malignant Lymphocytes (1989) (1)
Pillars article: T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells. J. Exp. Med. 1982. 155: 734-748. (2013) (1)
The Killer T Cell: Idiotypes, Regulation, and Immune Interferon (1981) (1)
Apoptosis in Monoclonal Antibody-Induced Tumor Regression (1989) (1)
Protein Synthesis of c-FLIP DeCD 95-Mediated Apoptosis Correlates with Resistance of Short Term Activated T Cells to (2004) (1)
Evidence for a role of immunosuppression in the pathogenesis of small cell lung cancer (1994) (1)
Activation-Induced Cell Death in Regulatory Expression Confers Resistance to Foxp 3-Mediated Suppression of CD 95 L (2011) (1)
Death of lymphocytes (1993) (1)
Educational Corner: Activation-induced T cell death. (1996) (1)
From the Department of Microbiology and the Immunology Graduate Program, University of Texas Health Science Center at Dallas, Dallas, Texas and the Institute for Immunology and Genetics, German Cancer (2003) (1)
AF-1 a novel regulator of the redox equilibrium during aging. (2014) (1)
Production of interferon-γ (IFN-γ) by a murine T cell clone from long term cultures (1981) (1)
Heterogeneity of macrophage-activating factors (MAFs) and their effects in vivo. (1984) (1)
Release of Prostaglandins and Modulation of Leukocyte Functions (1986) (1)
A simple method for cryopreservation of murine T-cell clones from long-term cultures. (1981) (1)
Death-Inducing Signaling Complex Activity CD 95-Mediated Apoptosis by Blocking Correlates with Resistance Toward shortTCR-Mediated Up-Regulation of c-FLIP (2000) (1)
CD28 Costimulation in T Cells to Mediate IL-4 Gene Expression in Response to Θ Vav Synergizes with Protein Kinase C (2017) (0)
APO-1/FAS mediated apoptosis in normal and malignant lymphocytes (1993) (0)
Hepatitis C virus core protein inhibits apoptosis through functional modulation of the PML/p53 tumor suppressor pathway (2005) (0)
ASPECTS OF ALLOREACTIVTTY: LYMPHOKINE RELEASE FROM ALLOREACTIVE T CELL CLONES IN LONG-TERM CULTURE (1982) (0)
Hepatitis B Virus Infection triggers AP–1 dependent CD95Ligand expression in HepG2 cells (2012) (0)
Interaction of Hepatitis B virus (HBV) with p53 family-induced apoptosis signaling pathways is involved in viral clearance (2009) (0)
CD95(APO-1/Fas)-mediated apoptosis: regulation of life and death (2001) (0)
The Proliferation Inhibitor CDKN1C (P57KIP2) Is Over Expressed in CD34+ Cells of Patients with MDS and Determines a Worse Prognosis Independently of IPSS Score Factors (2012) (0)
Activation-Induced T Cell Death Substitutes for Oxidative Signaling in HIV-1 Trans-Activator of Transcription (2005) (0)
Immune Interferon Production by T-Cell Clones (1982) (0)
Protein in the regulation of apoptosis (1998) (0)
11P6Manganese superoxide dismutase controls T cell activation-induced oxidative signaling and cell death (2012) (0)
TGF-beta-induced apoptosis can be mediated via TRAIL in hepatoma cells (2005) (0)
HETEROGENEITY OF T CELL SURFACE MARKERS AND TERMINAL TRANSFERASE OF AKR LYMPHOMAS: A CLUE TO FUNCTIONAL HETEROGENEITY (1979) (0)
F.101. Kinetics of Cytokine Suppression in CD4+CD25- Effector T-Cells By CD4+CD25++ Regulatory T-Cells in Humans (2006) (0)
CD95L-mediated immunosuppression by tumors (1997) (0)
Fractionated irradiation sensitizes tumor cells to apoptoticsignals through CD95. (1999) (0)
Ciprofloxacin-Mediated Immunosuppression and IL-4 Expression: Mechanism of Control T Cell Activation by Regulating IL-2 Mitochondrial Reactive Oxygen Species (2010) (0)
Wogonin and Related Natural Flavones Overcome TRAIL-resistance of Tumors by Down-regulation of c-FLIP and Up-regulation of TRAIL-R2 Expression (2011) (0)
Table of Contents (1995) (0)
Molecular Mechanism and Physiology of Apoptosis (2014) (0)
Apoptotic Cells Is Mediated by the Annexin The Tolerogenic Function of Annexins on (2015) (0)
Apoptosis in the immune system (2007) (0)
ELI PIKARSKY ENGINEERING IMMUNE EFFECTOR MOLECULES FOR NEW CANCER IMMUNOTHERAPIES18 YORAM REITER P53 THE WILD TYPE AND MUTANTS - THIRTY YEARS OF RESEARCH (2010) (0)
Alloreactive and TNP-specific cytotoxic T lymphocytes from murine peripheral blood in microculture in the presence of T cell growth factors (1980) (0)
Dissection of the Fas‐signaling pathway in Fas‐sensitive and Fas‐resistant human B cells (1999) (0)
No conference critique (1998) (0)
CONTINUOUS CULTURE OF LYMPHOCYTES WORKSHOP SUMMARY (1979) (0)
The producer cell of interferon in murine lymphocyte cultures. (1981) (0)
Flow-cytometric Detection of Low-level Reactive Oxygen Species in Cell Lines and Primary Immune Cells. (2020) (0)
Supplementary Figure S4 (2011) (0)
HIV-1 Tat and T cell apoptosis (2006) (0)
Diagnostics and Experimental Therapy (1998) (0)
444 CD95LIGAND EXPRESSION IN HEPATITIS B VIRUS INFECTED HEPATOCYTES IS MEDIATED VIA THE TRANSCRIPTIONFACTOR AP-1 (2012) (0)
We investigated the role of cytokines for the growth of CD4-8- thymocytes (double negative thy- mocytes) (DNT) in vitro and found that IL-1-induced (1989) (0)
The p53 family network induces apoptosis and chemosensitivity in hepatocellular carcinoma (2008) (0)
Procede d'evaluation de l'activite de substances medicamenteuses (1996) (0)
Role of Antioxidative Defence in Activation Induced Cell Death (2010) (0)
THE MHC INFLUENCE ON T CELL RECEPTOR EXPRESSION (1980) (0)
Monoclonal antibodies against cell surface antigens on a malignant b cell line associated with cytokine induced immunoglobulin secretion (1987) (0)
Activation of the gamma 1 gene by lipopolysaccharide and T cell-derived lymphokines containing a B cell differentiation factor for IgG1 (BCDF gamma). (1985) (0)
The role of apoptosis in AIDS (2005) (0)
CD95/CD95 Ligand (Fas/Fasl, APO‐1/APO‐1L) (2002) (0)
Table of Contents (1995) (0)
[Normal colon epithelium is highly sensitive to CD95-induced apoptosis. Indication for a role of cell death-induced CD95/CL95L systems under inflammatory inflammatory conditions?]. (1996) (0)
Annexin A1 suppresses immune responses in vivo . (2013) (0)
The CD95(APO-1/FAS)-mediated death signal and diseases (1998) (0)
The Early Growth Response Protein-1 (Egr-1) Is Preferentially Expressed in Th2 Cell and Is Involved in Acute Transcription of the Th2 Cytokine Interleukin-4 (2009) (0)
Analysis of FOXP3+ regulatory T cell subpopulations in peripheral blood and tissue of patients with systemic lupus erythematosus (2017) (0)
Molecular and functional heterogeneity of 2 t cell derived macrophage activating factors (1982) (0)
INTERLEUKIN-1 INDUCED GROWTH OF DOUBLE-NEGATIVE (L3T4- AND LYT2-) IMMATURE MOUSE THYMOCYTES IS INITIATED BY INDUCING THE SYNTHESIS OF INTERLEUKIN-2 RECEPTOR MESSENGER-RNA (1987) (0)
Letter to the Editor (1999) (0)
[Apoptosis in the immune system: murder or suicide]. (1996) (0)
T-cell tumor growth by inducing PLC { gamma } 1-and Ca 2 +-dependent Wogonin preferentially kills malignant lymphocytes and suppresses (2008) (0)
REQUIREMENT OF ENDOGENOUS RECOVERY FROM TUMOR NECROSIS FACTOR / CACHECTIN FOR EXPERIMENTAL PERITONITIS 1 (2001) (0)
Treatment resistance analysis reveals GLUT‐1‐mediated glucose uptake as a major target of synthetic rocaglates in cancer cells (2021) (0)
The APO-1 (FAS/CD95)-mediated death-signal and immune diseases (1998) (0)
Primary human hepatocytes are resistant to trail-induced apptosis and are not sensitised for trail-induced apoptosis by chemotherapeutic drugs (2003) (0)
P63 induces apoptosis of hepatocytes via death receptors and mitochondria and show a synergistic effect when combined with chemotherapeutic drugs (2003) (0)
PURE , ISAKSON , KAPPLER , MARRACK , KRAMMER , AND VITETTA 601 Materials and Methods Animals (2003) (0)
281 TGF-β is involved in the regulation of apoptosis via trail expression in hepatoma cells (2004) (0)
Jürg Tschopp—1951–2011—an immortal contribution (2011) (0)
A T cell-derived B-cell differentiation factor (BCDFγ) which induces an isotype switch in normal murine B cells☆☆☆ (1982) (0)
289 Functional cooperation between Smad proteins and activator protein-1 regulates transforming growth factor-beta-mediated induction of tnf-related apoptosis-inducing ligand (2006) (0)
ORIGIN AND SPECIFICITY OF SURFACE IMMUNOGLOBULIN ON MLR ACTIVATED MOUSE T CELLS (1976) (0)
P53 and Fas/APO-1 induction in hepatoma cells in response to treatment with DNA damaging agents (1995) (0)
Internalization of IL-1 is required for IL-2 gene activation in EL4 thymoma cells (1990) (0)
Target NF-AT Activity in T Cells Immunosuppressive Phytochemicals That Rocaglamide Derivatives Are (2005) (0)
Long-term survival after complete response to chemotherapy in small cell lung cancer depends on cytokine secretion capacity at diagnosis (1997) (0)
Lymphokines. (1972) (0)
Activation of tumoricidal and schistosomulicidal macrophages by sequential lymphokine signals (1985) (0)
Regulation of the CD95 gene by the p53 family network- the intronic binding site is essential (2008) (0)
555 Level of interleukin-2 at the time of diagnosis is predictive for response to chemotherapy and associated with survival in patients with small cell lung cancer (1997) (0)
Der Rezeptor für advanced glycation end products (RAGE) mediiert Inflammation und fördert Tumorentstehung durch Interaktion mit Apoptosesignalwegen (2008) (0)
HIV-Tat enhances Oxidative Signalling in Activation Induced Cell Death (2006) (0)
and Function in CTL The Regulation of CD95 Ligand Expression (1998) (0)
ApoptosisTh 2 Resistance from Fas-Mediated Death-Inducing Complex : A Mechanism for Th 2 Cells Inhibits Caspase-8 Cleavage at the-Kinase Activity in ′ Phosphatidylinositol 3 Selective Up-Regulation of (1999) (0)
Influence of TGF β1 and chemotherapy on cytokine secretion in SCLC (1994) (0)
The European Cell Death Group (2001) (0)
Anticancer drugs induce CD95L and subsequent apoptosis in liver cellsvia activation of a novel AP-1 element in the CD95L promoter (2000) (0)
Costimulation Induced by T Cell θ Protein Kinase C Activation and Lipid Raft Recruitment of B κ 1 Are Required for NF-γ Phospholipase C Leukocyte Phosphoprotein of 76 kDa and Src Homology 2 Domain-Containing (2002) (0)
Wogonin sensitizes resistant malignant cells to TNFα- and TRAIL-induced apoptosis Running title: Wogonin sensitizes TNFα- and TRAIL-induced apoptosis (2006) (0)
CD4+CD25 high regulatory T-cells of patients with Multiple Sclerosis have a reduced suppressive effect on proliferation and cytokine secretion of responder T-cells (2004) (0)
Disc analysis of drug modulated sensitivity of human hepatoma cell lines for trail-induced apoptosis (2001) (0)
Perforin Knockout Mice Rejected in Anti-Tumor TCR Transgenic CD 95 Ligand-Expressing Tumors Are (2001) (0)
Activation-Induced Cell Death Human T Cells Toward CD95-Mediated Signaling Pathways Sensitizes Primary An IL-2-Dependent Switch Between CD95 (2003) (0)
Optilene , a new non-absorbable mono fi lament is safe and e ff ective for CABG anastomosis . OPTICABG-A prospective international , multi-centric , cohort study (2003) (0)
Phorbol myristic acetate (PMA) enhances growth of interleukin-2 (IL-2) dependent T cell-lines (TCL) (1981) (0)
Inhibition of TNF and CD95 (APO-1/Fas) ligand as a novel therapy for stroke (2002) (0)
Inhibition of CD95-independent apoptosis in AIDS (1998) (0)
MURINE T-CELL LYMPHOMAS, A MODEL SYSTEM FOR MOUSE T CELLS (1976) (0)
CHARACTERIZATION OF T-CELL-CYTOTOXICITY-INDUCING-FACTOR 1 (TCF-1), A T-CELL PRODUCT THAT INDUCES MURINE THYMOCYTE DIFFERENTIATION (1987) (0)
Mitochondria as Oxidative Signaling Organelles in T-cell Activation: Physiological Role and Pathological Implications (2013) (0)
TNF in peritonitis of the mouse (1992) (0)
apoptosis T-cell tumor growth by inducing PLC{gamma}1- and Ca2+-dependent Wogonin preferentially kills malignant lymphocytes and suppresses (2009) (0)
Inhibition of Antibody Production in Vitro with Bispecific CD20 X CD95 Antibodies (2011) (0)
Molecular analysis of Annexin expression in cancer (2022) (0)
Inhibitors of TCR Signaling , and Various β IL-2 Consumption , TGF-Regulatory T Cells : Independence of + Foxp 3 + T Cells by CD 4 − CD 25 + in Human CD 4 Rapid Suppression of Cytokine Transcription (2007) (0)
PURIFICATION OF T-CELL-CYTOTOXICITY-INDUCING-FACTOR-1 (TCF-1), A LYMPHOKINE INVOLVED IN THE DIFFERENTIATION OF CYTO-TOXIC T-CELLS (1988) (0)
Production of interferom-γ by lectin stimulation of cells derived from short-term cultures of activated murine spleen leukocytes (1982) (0)
Early detachment of colon carcinoma cells during D95<APO-1/Fas mediated apoptosis. II. De-adhesion from collagen due to depletion of surface integrlns by membrane blobbing (1996) (0)
Process for the preparation of interferon-stimulated II and clones to ydfoerelse of frmgangsmaaden (1981) (0)
Regulation of Hematopoietic Differentiation and Its Disruption Group Report (1985) (0)
Mitochondrial Respiratory Chain derived Reactive Oxygen Species are Crucial for Activation-Induced CD95 Ligand Expression (2006) (0)
Neuroectodermal Tumors p 53-independent Apoptosis via Activation of Caspases in Betulinic Acid Triggers CD 95 ( APO-1 / Fas )-and Updated Version (2006) (0)
The growth factor antagonist suramin inhibits death receptor induced apoptosis in the liver (2003) (0)
Science Signaling Podcast: 20 December 2011 (2011) (0)
Macrophage activation for Trichomonas vaginalis killing induced by lymphokines from T cell clones (1983) (0)
Engagement of pro- and antiapoptotic mechanisms in liver cells following administration of chemotherapeutic drugs revealed by microarray analysis (2000) (0)
Erratum: Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia (Proceedings of the National Academy of Sciences of the United States of America (April 13, 1999) 96, 8 (4552-4557)) (2004) (0)
AF-1 Controls Stress Resistance in Aged T Cells (2010) (0)
Activation or suppression of NFjB by HPK1 determines sensitivity to activation-induced cell death (2005) (0)
Overcoming cell death resistance in cutaneous T cell lymphoma (CTCL) by combined Bcl-2 and NFκB inhibition (2018) (0)
Stimulation of macrophage activity by 12-O-tetradecanoylphorbol-13-acetate. (1984) (0)
The Protein Phosphatase 2A Regulatory Subunit B56 (cid:2) Mediates Suppression of T Cell Receptor (TCR)-induced Nuclear Factor- (cid:3) B (NF- (cid:3) B) Activity * (2014) (0)
Promoter 1-Dependent Domains in the CD 95 Ligand Positive Regulatory IFN-Regulatory Factor Activation-Induced Cell Death Via Two Viral IFN-Regulatory Factors Inhibit (2002) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Peter Heinrich Krammer?

Peter Heinrich Krammer is affiliated with the following schools:

Peter Heinrich Krammer's Academic­Influence.com Rankings

Peter Heinrich Krammer's Degrees

Why Is Peter Heinrich Krammer Influential?

Peter Heinrich Krammer's Published Works

Published Works

What Schools Are Affiliated With Peter Heinrich Krammer?

Peter Heinrich Krammer's AcademicInfluence.com Rankings